Misty Witten
Family · Austin, TXNPI 1427449305
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.4% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations.
Across 63 payments — averaging $27.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$362
- GSK$235
- Sanofi$168
- Amgen$163
- ADMA Biomanufacturing LLC$116
- Viiv Healthcare Company$109
- plus $574 from 16 others
What the payments were for
- Consulting fees$1167%
- Food & beverage$1,59692%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 7 | $362 |
| GSK | 12 | $235 |
| Sanofi | 2 | $168 |
| Amgen(2 entities) | 13 | $163 |
| ADMA Biomanufacturing LLC | 3 | $116 |
| Viiv Healthcare Company | 2 | $109 |
| CSL Behring | 2 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $66 |
| Daiichi Sankyo Inc. | 3 | $62 |
| AbbVie | 3 | $57 |
| Argenx US, Inc. | 2 | $44 |
| Biogen | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Pharmacosmos Therapeutics Inc. | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Chiesi USA, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $25 |
| Genentech USA, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Eisai Inc. | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
How this compares
$1,727 in reported general payments places this provider in the 75th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Austin
- Monique MulvanyAustin$142K
- Barry HughesAustin$51K
- Eric PerezAustin$42K
- Chelsea CrillyAustin$36K
- Alexandra RossiAustin$35K
- Angelina DetmersAustin$33K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.